GlassScriptPhysician profile
Marshall George Balding
NPI 1528023793
$1,773.62
in general payments reported to CMS, 2019-2025
10 companies · $593 in 2025
The $593 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $25.77 · 2022: $304 · 2023: $398 · 2024: $453 · 2025: $593.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,444.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,444.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $559.83 | 2023-2024 | Variax, Actishield, 7 X 23mm Citrelock Implant |
| Kerecis Limited | $469.81 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Treace Medical Concepts, INC. | $246.38 | 2023-2025 | |
| Depuy Synthes Sales INC. | $159.97 | 2022 | |
| Biotissue Holdings INC. | $122.01 | 2022 | |
| Globus Medical, INC. | $89.71 | 2024 | Harvest |
| Flower Orthopedics Coporation | $42.00 | 2025 | |
| Acumed LLC | $36.45 | 2023 | Osteomed, Acumed |
| Misonix INC | $25.77 | 2020 | |
| Abbott Laboratories | $21.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marshall Balding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.